Current Report Filing (8-k)
May 29 2018 - 7:17AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
______________
FORM 8-K
______________
Current
Report
Pursuant
to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of
Report (Date of earliest event reported): May 29, 2018 (May 25, 2018)
______________
MOLINA
HEALTHCARE, INC.
(Exact
name of registrant as specified in its charter)
Delaware
|
1-31719
|
13-4204626
|
(State or other jurisdiction of
incorporation)
|
(Commission File Number)
|
(I.R.S. Employer Identification No.)
|
______________
200 Oceangate, Suite 100, Long Beach, California 90802
|
(Address of principal executive offices)
|
Registrant’s
telephone number, including area code:
(562) 435-3666
Check the
appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any
of the following provisions:
⃞
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)
⃞
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
⃞
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR
240.14d-2(b))
⃞
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR
240.13e-4(c))
Item 5.02. Departure of Directors or Certain Officers; Election of
Directors; Appointment of Certain Officers; Compensatory Arrangements of
Certain Officers.
On May 25, 2018, the board of directors (the “Board”) of Molina
Healthcare, Inc. (the “Company”) elected Richard Zoretic to serve as a
Class II director, effective August 1, 2018, filling an existing vacancy
in Class II of the Board. The term of the Class II directors will expire
at the Company’s 2019 annual meeting. As of the date of his election,
Mr. Zoretic had not been named to any committees of the Board.
There are no arrangements or understandings between Mr. Zoretic and any
other persons pursuant to which he was selected as a director, nor are
there any transactions that would be required to be reported pursuant to
Item 404(a) of Regulation S-K.
Mr. Zoretic, age 60, retired in May 2014 as Executive Vice President of
WellPoint, Inc. and President of its Government Business Division, which
includes all operations related to Medicare, Medicaid, National
Government Services, and the Federal Employee Program. Prior to joining
WellPoint, Mr. Zoretic served as executive vice president and chief
operating officer of Amerigroup Corporation, where he was responsible
for health plan operations, provider networks, health care economics,
health care management services, technology and customer service
operations. Mr. Zoretic joined Amerigroup in September 2003 as chief
marketing officer and assumed responsibility for all health plan
operations in 2005. Mr. Zoretic was appointed chief operating officer in
2007. Prior to Amerigroup, Mr. Zoretic held senior leadership positions
at UnitedHealth Group and at MetLife Group, and served as a management
consultant in Deloitte Consulting’s health care practice.
Item 7.01. Regulation FD Disclosure.
A copy of the press release relating to Mr. Zoretic’s election to the
Board is attached hereto as Exhibit 99.1.
Note: The information furnished herewith pursuant to Item 7.01 of this
Current Report on Form 8-K shall not be deemed to be “filed” for the
purpose of Section 18 of the Securities Exchange Act of 1934, as amended
(the “Exchange Act”) or otherwise subject to the liabilities of that
section, and shall not be incorporated by reference into any
registration statement or other document filed by the Company under the
Securities Act of 1933, as amended, or the Exchange Act, except as shall
be expressly set forth by specific reference in such filing.
Item 9.01. Financial Statements and Exhibits.
(d)
|
Exhibits
|
|
|
Exhibit
|
|
No.
|
Description
|
|
|
99.1
|
Press release of Molina Healthcare, Inc. dated May 29, 2018.
|
SIGNATURE
Pursuant to
the requirements of the Securities Exchange Act of 1934, the registrant
has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
|
|
MOLINA HEALTHCARE, INC.
|
|
|
|
Date:
|
May 29, 2018
|
By:
|
/s/ Jeff D. Barlow
|
|
|
Jeff D. Barlow
|
|
|
Chief Legal Officer and Secretary
|
EXHIBIT INDEX
Molina Healthcare (NYSE:MOH)
Historical Stock Chart
From Apr 2024 to May 2024
Molina Healthcare (NYSE:MOH)
Historical Stock Chart
From May 2023 to May 2024